Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Schelenz, Silke ^a   Ross, Calum N ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; INSULIN; ITRACONAZOLE; PYRROLE; VORICONAZOLE;

ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BLADDER DISEASE; CANDIDA GLABRATA; CANDIDIASIS; CASE REPORT; DRUG EFFICACY; DRUG INSTILLATION; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HYDRONEPHROSIS; INTENSIVE CARE; LABORATORY TEST; LONG TERM CARE; LOW BACK PAIN; MINIMUM INHIBITORY CONCENTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERCUTANEOUS DRAINAGE; PYONEPHROSIS; RECURRENT INFECTION; REVIEW; RIGOR; SEPSIS; URETER CATHETERIZATION; URETER OBSTRUCTION; URETER STENT; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; URINE CULTURE; VOMITING;

AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; AZOLES; CANDIDA GLABRATA; DRUG RESISTANCE, MULTIPLE, FUNGAL; ECHINOCANDINS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; PEPTIDES, CYCLIC; PYELONEPHRITIS;

EID: 33748633782     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-126     Document Type: Review

References (15)

1. Ng CK, Yip SK, Sim LS, Tan BH, Wong MY, Tan BS, Htoo A: Outcome of percutaneous nephrostomy for the management of pyonephrosis. Asian J Surg 2002, 25:215-9.
2. Barchiesi F, Schimizzi AM, Fothergill AW, Scalise G, Rinaldi MG: In vitro activity of new echinocandin antifungal, MK-0991 against common and uncommon clinical isolates of Candida species. Eur J Clin Microbiol Infect Dis 1999, 18:302-304.
3. Pappas PG, Rex JH, Sobel JD, et al: Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161-189.
4. Schelenz S, Gransden WR: Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 2003, 46:390-6.
5. Barchiesi F, Spreghini F, Tomassetti S, Arzeni D, Giannini D, Scalise G: Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob Agents Chemother 2005, 49:4989-92.
6. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J: Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002, 347:2020-2029.
7. Villanueva A, Gotuzzo E, Arathoon EG, Noriega LM, Kartsonis NA, Lupinacci RJ, Smietana JM, DiNubile MJ, Sable CA: A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med 2002, 113:294-299.
8. Lye DC, Hughes A, O'Brien D, Athan E: Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis 2005, 24:753-755.
9. Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, Kropp H: Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrob Agents Chemother 1997, 41:2339-2344.
10. Stone JA, Xu X, Winchell GA, Deutsch PJ, Pearson PG, Migoya EM, Mistry GC, Xi L, Miller A, Sandhu P, Singh R, deLuna F, Dilzer SC, Lasseter KC: Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma. Antimicrob Agents Chemother 2004, 48:815-23.
11. Barchiesi F, Spreghini E, Fothergill AW, Arzeni D, Greganti G, Giannini D, Rinaldi MG, Scalise G: Càspofungin in combination with amphotericin B against Candida glabrata. Antimicrob Agents Chemother 2005, 49:2546-9.
12. Balani SK, Xu X, Arison BH, Silva MV, Gries A, DeLuna FA, Cui D, Kari PH, Ly T, Hop CE, Singh R, Wallace MA, Dean DC, Lin JH, Pearson PG, Baillie TA: Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine. Drug Metab Dispos 2000, 28:1274-1278.
13. Arend SM, Kuijper EJ, de Vaal BJ, de Fijter JW, Van't Wout JW: Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient. Eur J Clin Microbiol Infect Dis 2005, 20:1-3.
14. Clark MA, Gaunt T, Czachor JS: The use of fluconazole as a local irrigant for nephrostomy tubes. Mil Med 1999, 164:239-241.
15. Bell DA, Rose SC, Starr NK, Jaffe RB, Miller FJ Jr: Percutaneous nephrostomy for nonoperative management of fungal urinary tract infections. J Vasc Interv Radiol 1993, 4:311-5.